Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,579 | 798 | 99.8% |
| Education | $20.90 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,134 | 206 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,693 | 163 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $950.49 | 86 | $0 (2024) |
| Janssen Biotech, Inc. | $619.00 | 45 | $0 (2024) |
| QOL Medical, LLC | $544.27 | 62 | $0 (2024) |
| Celgene Corporation | $451.55 | 40 | $0 (2024) |
| PFIZER INC. | $448.30 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $314.66 | 15 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $268.50 | 19 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $212.29 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,272 | 153 | ABBVIE INC. ($611.87) |
| 2023 | $1,725 | 121 | AbbVie Inc. ($643.03) |
| 2022 | $1,552 | 119 | ABBVIE INC. ($553.47) |
| 2021 | $1,157 | 111 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($459.23) |
| 2020 | $792.98 | 61 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($274.80) |
| 2019 | $896.70 | 76 | AbbVie, Inc. ($266.70) |
| 2018 | $888.14 | 83 | Synergy Pharmaceuticals Inc ($181.33) |
| 2017 | $1,317 | 79 | AbbVie, Inc. ($614.61) |
All Payment Transactions
803 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: LIVER DISEASE | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $13.31 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Immunology | ||||||
| 11/24/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $120.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 616 | 690 | $403,979 | $74,757 |
| 2022 | 8 | 560 | 645 | $352,483 | $64,204 |
| 2021 | 11 | 669 | 767 | $409,333 | $76,645 |
| 2020 | 13 | 530 | 624 | $259,652 | $53,704 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 285 | $80,940 | $29,599 | 36.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 56 | 57 | $82,080 | $12,462 | 15.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 85 | 85 | $117,725 | $8,284 | 7.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 114 | $22,800 | $8,065 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $21,170 | $7,768 | 36.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 50 | 50 | $60,250 | $4,195 | 7.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $12,840 | $2,108 | 16.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,182 | $1,561 | 37.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,992 | $716.20 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 231 | $65,604 | $23,150 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 135 | $27,000 | $9,513 | 35.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 44 | 44 | $63,360 | $9,320 | 14.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 78 | 78 | $108,030 | $8,460 | 7.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $19,955 | $6,847 | 34.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $57,840 | $3,527 | 6.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,548 | $1,779 | 32.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 31 | 31 | $5,146 | $1,608 | 31.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 208 | $58,688 | $21,266 | 36.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 159 | 193 | $38,327 | $14,047 | 36.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 94 | 95 | $130,135 | $11,455 | 8.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 38 | 39 | $54,966 | $8,561 | 15.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $12,780 | $4,782 | 37.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 59 | 60 | $72,300 | $4,693 | 6.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 44 | 44 | $10,340 | $3,639 | 35.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 15 | 15 | $16,050 | $2,757 | 17.2% |
About Dr. Elizabeth Egan, MD
Dr. Elizabeth Egan, MD is a Gastroenterology healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174685416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Egan, MD has received a total of $10,600 in payments from pharmaceutical and medical device companies, with $2,272 received in 2024. These payments were reported across 803 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($10,579).
As a Medicare-enrolled provider, Egan has provided services to 2,375 Medicare beneficiaries, totaling 2,726 services with total Medicare billing of $269,310. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Voorhees, NJ
- Active Since 12/14/2006
- Last Updated 09/03/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1174685416
Products in Payments
- XIFAXAN (Drug) $1,074
- Humira (Biological) $559.98
- RINVOQ (Biological) $541.59
- ENTYVIO (Biological) $501.04
- TRULANCE (Drug) $500.32
- LINZESS (Drug) $470.07
- XELJANZ (Drug) $448.30
- ZEPOSIA (Drug) $443.97
- STELARA (Biological) $431.55
- Sucraid (Drug) $425.45
- DUPIXENT (Biological) $384.81
- HUMIRA (Biological) $363.68
- SKYRIZI (Biological) $356.34
- ZENPEP (Drug) $266.09
- Amitiza (Drug) $235.28
- CREON (Drug) $223.09
- INTERSTIM (Device) $203.26
- Trulance (Drug) $195.93
- MAVYRET (Drug) $184.14
- Linzess (Drug) $171.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Voorhees
Dr. Sanket Patel, D.o, D.O
Gastroenterology — Payments: $39,650
Dr. Alan Mushnick, Md, MD
Gastroenterology — Payments: $26,516
Dr. Michael Goldstein, Md, MD
Gastroenterology — Payments: $10,508
Alex Celluzzi, Do, DO
Gastroenterology — Payments: $9,192
Andrew Alloy, Do, DO
Gastroenterology — Payments: $9,041
Christopher Morrison, M.d, M.D
Gastroenterology — Payments: $7,129